Risk factors for community-acquired bacterial meningitis

References

• Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337:970–976.
   PubMed Web of Science ®Google Scholar
• Levy C, Varon E, Picard C, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014;33:1216–1221.
   PubMed Web of Science ®Google Scholar
• Olarte L, Barson WJ, Barson RM, et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis. 2015;61:767–775.
   PubMed Web of Science ®Google Scholar
• Levy C, Varon E, Béchet S, et al. Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children. Clin Infect Dis. 2016;62:131–132.
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, et al. Impact of 13-valent pneumococcal conjugate vaccine used in children on invasive pneumococcal disease in children and adults in the United States: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301–309.
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Dalby T, Weinberger DM, et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014;59:1066–1073.
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50:184–191.
   PubMed Web of Science ®Google Scholar
• Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–492.
   PubMed Web of Science ®Google Scholar
• Levine OS, Farley M, Harrison LH, et al. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. 1999;103:E28.
   PubMed Web of Science ®Google Scholar
• Takala AK, Jero J, Kela E, et al. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA. 1995;273:859–864.
   PubMed Web of Science ®Google Scholar
• Hjuler T, Wohlfahrt J, Simonsen J, et al. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study. Clin Infect Dis. 2007;44:1051–1056.
   PubMed Web of Science ®Google Scholar
• Churchill RB, Pickering LK. Infection control challenges in child-care centers. Infect Dis Clin N Am. 1997;11:347–365.
   PubMed Web of Science ®Google Scholar
• Petraitiene S, Alasevicius T, Staceviciene I, et al. The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children. BMC Infect Dis. 2015;15:403.
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Zell ER, Farley MM, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics. 2010;126:e9–e17.
   PubMed Web of Science ®Google Scholar
• Spicer JO, Thomas S, Holst A, et al. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2014;33:158–164.
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681–689.
   PubMed Web of Science ®Google Scholar
• Chun CS, Weinmann S, Riedlinger K, et al. Passive cigarette smoke exposure and other risk factors for invasive pneumococcal disease in children: a case-control study. Perm J. 2015;19:38–43.
   PubMedGoogle Scholar
• Pereiró I, Díez-Domingo J, Segarra L, et al. Risk factors for invasive disease among children in Spain. J Infect. 2004;48:320–329.
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report (MMWR). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23). MMWR. 2010;59:1102–1106.
   PubMedGoogle Scholar
• Cruickshank HC, Jefferies JM, Clarke SC. Lifestyle risk factors for invasive pneumococcal disease: a systematic review. BMJ Open. 2014;4:e005224.
   PubMed Web of Science ®Google Scholar
• Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA. 1996;275:194–198.
   PubMed Web of Science ®Google Scholar
• Preventing Pneumococcal Disease Among Infants and Young Children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Advisory Committee on Immunization Practices Membership List; June 2000 [Internet]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4909a1.htm
   Google Scholar
• Adriani KS, Brouwer MC, van de Beek D. Risk factors for community-acquired bacterial meningitis in adults. Neth J Med. 2015;73:53–60.
   PubMed Web of Science ®Google Scholar
• Weisfelt M, de Gans J, van der Ende A, et al. Community-acquired bacterial meningitis in alcoholic patients. PLoS One. 2010;5:e9102.
   PubMed Web of Science ®Google Scholar
• Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16:979–983.
   PubMed Web of Science ®Google Scholar
• Tully J, Viner RM, Coen PG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006;332:445–450.
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report (MMWR). Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-2):1–22.
   Web of Science ®Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis. 1999;180:1894–1901.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989?1991. MMWR CDC Surveill Summ. 1993;42:21–30.
   PubMedGoogle Scholar
• Stuart JM, Cartwright KA, Robinson PM, et al. Effect of smoking on meningococcal carriage. Lancet. 1989;2:723–725.
   PubMed Web of Science ®Google Scholar
• Murray RL, Britton J, Leonardi-Bee J. Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis. BMC Public Health. 2012;12:1062.
   PubMed Web of Science ®Google Scholar
• McCall BJ, Neill AS, Young MM. Risk factors for invasive meningococcal disease in southern Queensland, 2000–2001. Intern Med J. 2004;34:464–468.
   PubMed Web of Science ®Google Scholar
• Coen PG, Tully J, Stuart JM, et al. Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers? Int J Epidemiol. 2006;35:330–336.
   PubMed Web of Science ®Google Scholar
• Grein T, O’Flanagan D. Day-care and meningococcal disease in young children. Epidemiol Infect. 2001;127:435–441.
   PubMed Web of Science ®Google Scholar
• Rosenstein N, Levine O, Taylor JP, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA. 1998;279:435–439.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Dwyer DM, Maples CT, et al. Risk of meningococcal infection in college students. JAMA. 1999;281:1906–1910.
   PubMed Web of Science ®Google Scholar
• Neal KR, Nguyen-Van-Tam JS, Jeffrey N, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ. 2000;320:846–849.
   PubMed Web of Science ®Google Scholar
• Ridpath A, Greene SK, Robinson BF, et al. Risk factors for serogroup C meningococcal disease during outbreak among men who have sex with men, New York City, New York, USA. Emerg Infect Dis. 2015;21:1458–1461.
   PubMed Web of Science ®Google Scholar
• Takala AK, Clements DA. Socioeconomic risk factors for invasive Haemophilus influenzae type b disease. J Infect Dis. 1992;165:S11–S15.
   PubMed Web of Science ®Google Scholar
• Mäkelä PH, Takala AK, Peltola H, et al. Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis. 1992;165:S2–S6.
   PubMed Web of Science ®Google Scholar
• Olowokure B, Spencer NJ, Hawker J, et al. Invasive Haemophilus influenzae disease: an ecological study of sociodemographic risk factors before and after the introduction of Hib conjugate vaccine. Eur J Epidemiol. 2003;18:363–367.
   PubMed Web of Science ®Google Scholar
• Choi C. Bacterial meningitis in aging adults. Clin Infect Dis. 2001;33:1380–1385.
   PubMed Web of Science ®Google Scholar
• Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31:578–585.
   PubMed Web of Science ®Google Scholar
• Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Age Dev. 1999;108:1–7.
   PubMed Web of Science ®Google Scholar
• Baunbæk-Knudsen G, Sølling M, Farre A, et al. Improved outcome of bacterial meningitis associated with use of corticosteroid treatment. Infect Dis (Lond). 2016;48:281–286.
   PubMed Web of Science ®Google Scholar
• Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011;364:2016–2025.
   PubMed Web of Science ®Google Scholar
• EPI-NEWS. Meningococcal disease 2015 Purulent meningitis; 2015.
   Google Scholar
• Morbidity and Mortality Weekly Report (MMWR). Prevention of Pneumococcal Disease Among Infants and Children — Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(RR-11):1–18.
   Google Scholar
• Bosch AATM, van Houten MA, Bruin JP, et al. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. Vaccine. 2016;34:531–539.
   PubMed Web of Science ®Google Scholar
• Gladstone RA, Jefferies JM, Tocheva AS, et al. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine. 2015;33:2015–2021.
   PubMed Web of Science ®Google Scholar
• Lindstrand A, Galanis I, Darenberg J, et al. Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden. Vaccine. 2016;34:4565–4571.
   PubMed Web of Science ®Google Scholar
• http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx
   Google Scholar
• Stokley S, Cohn A, Dorell C, et al. Adolescent vaccination-coverage levels in the United States: 2006–2009. Pediatrics. 2011;128:1078–1086.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. Can we control all-cause meningococcal disease in Europe? Clin Microbiol Infect. 2016;22:S103–S112.
   PubMed Web of Science ®Google Scholar
• Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet. 2014;383:40–47.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1171–1176.
   PubMed Web of Science ®Google Scholar
• Briere EC, Rubin L, Moro PL, et al. Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63:1–14.
   PubMed Web of Science ®Google Scholar
• Peltola H. Haemophilus influenzae type b disease and vaccination in Europe: lessons learned. Pediatr Infect Dis J. 1998;17:S126–S132.
   PubMed Web of Science ®Google Scholar
• Ulanova M, Tsang RSW. Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol. 2009;9:594–605.
   PubMed Web of Science ®Google Scholar
• Nix EB, Hawdon N, Gravelle S, et al. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clin Vac Immunol. 2012;19:766–771.
   PubMed Web of Science ®Google Scholar
• Blain A, MacNeil J, Wang X, et al. Invasive Haemophilus influenzae disease in adults ≥65 years, United States, 2011. Open Forum Infect Dis. 2014;1:ofu044.
   PubMedGoogle Scholar
• Brouwer MC, de Gans J, Heckenberg SG, et al. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:31–44.
   PubMed Web of Science ®Google Scholar
• Schröder NWJ, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005;5:156–164.
   PubMed Web of Science ®Google Scholar
• Sanders MS, van Well GTJ, Ouburg S, et al. Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis. Genes Immun. 2011;12:321–334.
   PubMed Web of Science ®Google Scholar
• Yuan FF, Marks K, Wong M, et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2008;86:268–270.
   PubMed Web of Science ®Google Scholar
• Chapman SJ, Khor CC, Vannberg FO, et al. IkappaB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med. 2007;176:181–187.
   PubMed Web of Science ®Google Scholar
• Lundbo LF, Harboe ZB, Clausen LN, et al. Genetic variation in NFKBIE is associated with increased risk of pneumococcal meningitis in children. EBioMedicine. 2016;3:93–99.
   PubMed Web of Science ®Google Scholar
• Sanders MS, van Well GTJ, Ouburg S, et al. Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. Clin Infect Dis. 2011;52:475–480.
   PubMed Web of Science ®Google Scholar
• Doernberg S, Schaaf B, Dalhoff K, et al. Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. Cytokine. 2011;53:292–294.
   PubMed Web of Science ®Google Scholar
• Lundbo LF, Harboe ZB, Clausen LN, et al. Mannose-binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children. Clin Infect Dis. 2014;59:e66–e71.
   PubMed Web of Science ®Google Scholar
• Kronborg G, Weis N, Madsen HO, et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis. 2002;185:1517–1520.
   PubMed Web of Science ®Google Scholar
• Brouwer MC, Baas F, van der Ende A, et al. Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients. PLoS One. 2013;31:e65151.
   Web of Science ®Google Scholar
• Yuan FF, Wong M, Pererva N, et al. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2003;81:192–195.
   PubMed Web of Science ®Google Scholar
• Moens L, Van Hoeyveld E, Verhaegen J, et al. Fcgamma-receptor IIA genotype and invasive pneumococcal infection. Clin Immunol. 2006;118:20–23.
   PubMed Web of Science ®Google Scholar
• Hibberd ML, Sumiya M, Summerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet. 1999;353:1049–1053.
   PubMed Web of Science ®Google Scholar
• Faber J, Schuessler T, Finn A, et al. Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr Infect Dis J. 2007;26:243–246.
   PubMed Web of Science ®Google Scholar
• Lundbo LF, Sørensen HT, Clausen LN, et al. Mannose-binding lectin gene, MBL2, polymorphisms do not increase susceptibility to invasive meningococcal disease in a population of Danish children. Open Forum Infect Dis. 2015;2:ofv127.
   PubMed Web of Science ®Google Scholar
• Haralambous E, Dolly SO, Hibberd ML, et al. Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis. 2006;38:764–771.
   PubMed Web of Science ®Google Scholar
• Davila S, Wright VJ, Khor CC, et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet. 2010;42:772–776.
   PubMed Web of Science ®Google Scholar
• Tellería-Orriols JJ, García-Salido A, Varillas D, et al. TLR2-TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae. Med Intens. 2014;38:356–362.
   PubMed Web of Science ®Google Scholar
• Faber J, Meyer CU, Gemmer C, et al. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr Infect Dis J. 2006;25:80–81.
   PubMed Web of Science ®Google Scholar
• Endler G, Marculescu R, Starkl P, et al. Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. Clin Chem. 2006;52:511–514.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Davila S, Hibberd ML, et al. Association between single-nucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive Haemophilus influenzae serotype b infection in immunized children. Clin Infect Dis. 2010;51:761–767.
   PubMed Web of Science ®Google Scholar
• van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–1859.
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Larsen MV, Ladelund S, et al. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. Clin Infect Dis. 2014;59:1168–1176.
   PubMed Web of Science ®Google Scholar
• Domingo P, Suarez-Lozano I, Torres F, et al. Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;51:582–587.
   PubMed Web of Science ®Google Scholar
• van Veen KEB, Brouwer MC, van der Ende A, et al. Bacterial meningitis in patients with HIV: a population-based prospective study. J Infect. 2016;72:362–368.
   PubMed Web of Science ®Google Scholar
• Overton ET. An overview of vaccinations in HIV. Curr HIV/AIDS Rep. 2007;4:105–113.
   PubMedGoogle Scholar
• Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46:1–24.
   PubMedGoogle Scholar
• Thornhill J, Sivaramakrishnan A, Orkin C. Pneumococcal vaccination in people living with HIV. Vaccine. 2015;33:3159–3160.
   PubMed Web of Science ®Google Scholar
• Yin Z, Rice BD, Waight P, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000–2009. AIDS. 2012;26:87–94.
   PubMed Web of Science ®Google Scholar
• Miller L, Arakaki L, Ramautar A, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med. 2014;160:30–37.
   PubMed Web of Science ®Google Scholar
• Simmons RD, Kirwan P, Beebeejaun K, et al. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study. BMC Med. 2015;13:297.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Rubin LG, Patton M, et al. Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons – Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1189–1194.
   PubMed Web of Science ®Google Scholar
• Pinner RW, Onyango F, Perkins BA, et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis. 1992;166:359–364.
   PubMed Web of Science ®Google Scholar
• Brindle R, Simani P, Newnham R, et al. No association between meningococcal disease and human immunodeficiency virus in adults in Nairobi, Kenya. Trans R Soc Trop Med Hyg. 1991;85:651.
   PubMed Web of Science ®Google Scholar
• Cohen C, Singh E, Wu HM, et al. Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa. AIDS. 2010;24:1351–1360.
   PubMed Web of Science ®Google Scholar
• Mangtani P, Mulholland K, Madhi SA, et al. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine. 2010;28:1677–1683.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011;378:86–97.
   PubMed Web of Science ®Google Scholar
• Picard C, Puel A, Bustamante J, et al. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003;3:451–459.
   PubMed Web of Science ®Google Scholar
• Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197:939–945.
   PubMed Web of Science ®Google Scholar
• Adriani KS, Brouwer MC, van der Ende A, et al. Bacterial meningitis in adults after splenectomy and hyposplenic states. Mayo Clin Proc. 2013;88:571–578.
   PubMed Web of Science ®Google Scholar
• Francke EL, Neu HC. Postsplenectomy infection. Surg Clin N Am. 1981;61:135–155.
   PubMed Web of Science ®Google Scholar
• Kvalsvig AJ, Unsworth DJ. The immunopathogenesis of meningococcal disease. J Clin Pathol. 2003;56:417–422.
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Bousfiha A, Casanova J-L, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.
   PubMed Web of Science ®Google Scholar
• Ingels HAS. Recurrent invasive pneumococcal disease in children–host factors and vaccination response. Dan Med J. 2015;62:pii: B5126.
   PubMed Web of Science ®Google Scholar
• Ku C-L, Picard C, Erdös M, et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet. 2007;44:16–23.
   PubMed Web of Science ®Google Scholar
• Figueroa J, Andreoni J, Densen P. Complement deficiency states and meningococcal disease. Immunol Res. 1993;12:295–311.
   PubMed Web of Science ®Google Scholar
• Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine (Baltimore). 1993;72:374–392.
   PubMed Web of Science ®Google Scholar
• Oksenhendler E, Gérard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–1554.
   PubMed Web of Science ®Google Scholar
• Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis. 2000;31:973–980.
   PubMed Web of Science ®Google Scholar
• Costerus JM, Brouwer MC, van der Ende A, et al. Community-acquired bacterial meningitis in adults with cancer or a history of cancer. Neurology. 2016;86:860–866.
   PubMed Web of Science ®Google Scholar
• Pruitt AA. CNS infections in patients with cancer. Continuum (Minneap Minn). 2012;18:384–405.
   PubMedGoogle Scholar
• Guven GS, Uzun O, Cakir B, et al. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997–2001). Support Care Cancer. 2005;14:52–55.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Haas A. The epidemiology and treatment of infections in cancer patients. Int J Antimicrob Agents. 2008;31:193–197.
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003;4:595–604.
   PubMed Web of Science ®Google Scholar
• Safdieh JE, Mead PA, Sepkowitz KA, et al. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70:943–947.
   PubMed Web of Science ®Google Scholar
• Hjuler T, Wohlfahrt J, Staum Kaltoft M, et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics. 2008;122:e26–e32.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816–819.
   PubMedGoogle Scholar
• Patel SR, Ortín M, Cohen BJ, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, Meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis. 2007;44:625–634.
   PubMed Web of Science ®Google Scholar
• Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349:435–445.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices. Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2003;52:739–740.
   PubMedGoogle Scholar